The 23rd In Silico Megabank Research Seminar will be held on Friday, February 8.
This Time, we will be welcoming Dr. Mamoru Kato, National Cancer Center as our lecturer and he will be speaking on “Comparison of the Next-generation Sequencer Platform and Development of the Computer System for Clinical Sequencing.”

・Date/Time: February 8 (Fri.) 17:00‐18:30
・Venue: Conference Room 1 (2F), Tohoku Medical Megabank Organization
http://www.megabank.tohoku.ac.jp/english/info/access.html
・Title: Comparison of the Next-generation Sequencer Platform and Development of the Computer System for Clinical Sequencing
・Lecturer: Mamoru Kato （National Cancer Center）

・Abstract: While cancer-specific DNA mutations are cataloged by the large projects such as ICGC (International Cancer Genome Consortium) and TCGA (The Cancer Genome Atlas), clinical sequencing is now being implemented to serve as a bridge between the results of the study and the clinical practice. Clinical sequencing is a framework for the realization of the personalized medicine to make a proper selection of anticancer drugs, in which samples obtained at hospitals are sequenced by using the next-generation sequencer technology and decoded by referring to the catalog. National Cancer Center is now developing the system of clinical sequencing with an aim to start the operation from the next year, and our unit is working on the computer system development to deal with the sequence data and the comparative analysis of the sequence data such as Ion Torrent and HiSeq/MiSeq. In this seminar, I would like to discuss the characteristics of each platform data based on our experience as well as the selection of an appropriate algorism with regard to these ongoing topics.

・Organizer: Masao Nagasaki